US Global Invstr Financials
US Global Invstr (GROW) reported $8.5M in revenue for fiscal year 2025, down 23.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Shrinking revenue is colliding with a largely fixed cost base, turning a low-liability balance sheet into an operating cash-flow test.
From FY2024 to FY2025, revenue fell from$11.0M to$8.5M while selling, general and administrative spending stayed broadly stable, showing that the cost base did not contract with activity. The resulting operating loss widened from-4.4% to-35.3% , yet the net loss was only$334K against an operating loss of$3.0M , so non-operating items materially softened the reported bottom line.
Cash conversion deteriorated with the operating results: FY2025 operating cash flow was
The balance sheet is lightly encumbered: FY2025 debt-to-equity was 0.1x, with liabilities of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of US Global Invstr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
US Global Invstr has an operating margin of -35.3%, meaning the company loses $35 on every $100 of revenue. This results in a profitability score of 17/100. This is down from -4.4% the prior year.
US Global Invstr's revenue declined 23.1% year-over-year, from $11.0M to $8.5M. This contraction results in a growth score of 4/100.
US Global Invstr carries a low D/E ratio of 0.06, meaning only $0.06 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 83/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 20.87, US Global Invstr holds $20.87 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 99/100.
US Global Invstr's operations used $822K of cash, and capex of $7K added to the outflow, for a free cash flow shortfall of $829K. This results in a cash flow score of 32/100.
US Global Invstr posts a -0.7% return on equity (ROE), meaning it loses $1 for every $100 of shareholders' equity. This results in a returns score of 28/100. This is down from 2.7% the prior year.
US Global Invstr scores 10.62, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($41.3M) relative to total liabilities ($2.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
US Global Invstr passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
US Global Invstr reported a net loss of $334K while operations used $822K of cash. With neither figure positive, the ratio between the two carries no quality signal.
US Global Invstr reported an operating loss of $3.0M against $1K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
US Global Invstr generated $8.5M in revenue in fiscal year 2025. This represents a decrease of 23.1% from the prior year.
US Global Invstr's EBITDA was -$2.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 929.9% from the prior year.
US Global Invstr reported -$334K in net income in fiscal year 2025. This represents a decrease of 125.1% from the prior year.
US Global Invstr earned -$0.03 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 133.3% from the prior year.
Cash & Balance Sheet
US Global Invstr recorded an outflow of $829K in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 206.7% from the prior year.
US Global Invstr held $24.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.
US Global Invstr paid $0.01 per share in dividends in fiscal year 2025. That is unchanged from the prior year.
Margins & Returns
US Global Invstr's operating margin was -35.3% in fiscal year 2025, reflecting core business profitability. This is down 31.0 percentage points from the prior year.
US Global Invstr's net profit margin was -4.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 16.1 percentage points from the prior year.
US Global Invstr's ROE was -0.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
US Global Invstr spent $2.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 9.3% from the prior year.
US Global Invstr invested $7K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.7% from the prior year.
Not reported for fiscal year 2025.
GROW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M+10.0% | $2.5M+11.5% | $2.3M+14.8% | $2.0M-6.8% | $2.1M-5.7% | $2.2M+3.4% | $2.2M-11.6% | $2.4M |
| SG&A Expenses | $1.4M+18.9% | $1.2M-15.9% | $1.4M-2.6% | $1.4M-0.3% | $1.5M+4.2% | $1.4M-7.3% | $1.5M+12.6% | $1.3M |
| Operating Income | $88K+200.0% | -$88K+82.9% | -$515K+48.2% | -$995K-11.4% | -$893K-65.7% | -$539K+3.6% | -$559K-40.1% | -$399K |
| Interest Expense | $2K0.0% | $2K0.0% | $2K | $0 | $0 | $0-100.0% | $1K0.0% | $1K |
| Income Tax | -$844K-161.1% | $1.4M+309.8% | $337K+316.0% | -$156K-213.9% | $137K+556.7% | -$30K-124.8% | $121K-11.0% | $136K |
| Net Income | $2.7M+416.4% | -$846K-156.1% | $1.5M+932.6% | -$181K+52.6% | -$382K-344.2% | -$86K-127.3% | $315K0.0% | $315K |
| EPS (Diluted) | $0.21+400.0% | -$0.07-158.3% | $0.12+700.0% | -$0.02+33.3% | -$0.03-200.0% | -$0.01 | $0.020.0% | $0.02 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
GROW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $48.9M+3.6% | $47.2M-3.5% | $48.9M+1.8% | $48.1M-1.4% | $48.8M-2.7% | $50.1M-1.9% | $51.1M-1.7% | $52.0M |
| Current Assets | $38.1M-1.6% | $38.7M-1.1% | $39.1M0.0% | $39.1M-0.5% | $39.3M-1.7% | $40.0M-0.4% | $40.1M-0.4% | $40.3M |
| Cash & Equivalents | $24.6M-2.6% | $25.2M+2.6% | $24.6M+0.1% | $24.6M-6.5% | $26.3M+0.9% | $26.0M-4.7% | $27.3M-0.2% | $27.4M |
| Total Liabilities | $2.9M-5.8% | $3.0M+3.8% | $2.9M+2.9% | $2.9M+7.5% | $2.7M-5.8% | $2.8M+3.9% | $2.7M-8.1% | $3.0M |
| Current Liabilities | $1.8M-8.6% | $2.0M+4.5% | $1.9M+1.7% | $1.9M+3.4% | $1.8M-9.4% | $2.0M+4.5% | $1.9M-11.5% | $2.2M |
| Total Equity | $46.0M+4.3% | $44.2M-4.0% | $46.0M+1.7% | $45.2M-1.9% | $46.1M-2.5% | $47.3M-2.2% | $48.4M-1.3% | $49.0M |
| Retained Earnings | $38.4M+6.7% | $36.0M-3.0% | $37.2M+3.4% | $35.9M-1.3% | $36.4M-1.8% | $37.1M-1.0% | $37.5M0.0% | $37.5M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
GROW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $295K+15.2% | $256K+900.0% | -$32K-128.6% | -$14K+96.7% | -$425K-6.5% | -$399K-2593.8% | $16K-88.3% | $137K |
| Capital Expenditures | $20K | N/A | N/A | $1K0.0% | -$1K-85.7% | $7K | $0-100.0% | $34K |
| Free Cash Flow | $275K | N/A | N/A | -$15K+96.5% | -$426K-4.9% | -$406K-2637.5% | $16K-84.5% | $103K |
| Investing Cash Flow | -$124K-109.2% | $1.3M+82.4% | $738K+169.0% | -$1.1M-177.0% | $1.4M+11666.7% | -$12K-101.6% | $750K+41.8% | $529K |
| Financing Cash Flow | -$823K+14.4% | -$961K-43.0% | -$672K-7.2% | -$627K+15.4% | -$741K+16.3% | -$885K-6.8% | -$829K-14.0% | -$727K |
| Dividends Paid | $283K-1.4% | $287K-1.7% | $292K-1.4% | $296K-1.0% | $299K-2.0% | $305K-1.0% | $308K-1.6% | $313K |
| Share Buybacks | $552K-17.1% | $666K+70.8% | $390K-1.3% | $395K-12.8% | $453K-23.4% | $591K+11.5% | $530K+25.0% | $424K |
GROW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.2%+6.7pp | -3.5%+19.4pp | -22.9%+27.9pp | -50.7%-8.3pp | -42.5%-18.3pp | -24.2%+1.8pp | -25.9%-9.6pp | -16.4% |
| Net Margin | 96.9%+130.6pp | -33.7%-100.7pp | 67.0%+76.2pp | -9.2%+8.9pp | -18.2%-14.3pp | -3.9%-18.4pp | 14.6%+1.7pp | 12.9% |
| Return on Equity | 5.8%+7.7pp | -1.9%-5.2pp | 3.3%+3.7pp | -0.4%+0.4pp | -0.8%-0.7pp | -0.2%-0.8pp | 0.7%0.0pp | 0.6% |
| Return on Assets | 5.5%+7.3pp | -1.8%-4.9pp | 3.1%+3.5pp | -0.4%+0.4pp | -0.8%-0.6pp | -0.2%-0.8pp | 0.6%0.0pp | 0.6% |
| Current Ratio | 20.91+1.5x | 19.42-1.1x | 20.51-0.4x | 20.87-0.8x | 21.69+1.7x | 19.98-1.0x | 20.96+2.3x | 18.63 |
| Debt-to-Equity | 0.060.0x | 0.070.0x | 0.060.0x | 0.060.0x | 0.060.0x | 0.060.0x | 0.060.0x | 0.06 |
| FCF Margin | 10.0% | N/A | N/A | -0.8%+19.5pp | -20.3%-2.1pp | -18.2%-18.9pp | 0.7%-3.5pp | 4.2% |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Where US Global Invstr Ranks
Frequently Asked Questions
What is US Global Invstr's annual revenue?
US Global Invstr (GROW) reported $8.5M in total revenue for fiscal year 2025. This represents a -23.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is US Global Invstr's revenue growing?
US Global Invstr (GROW) revenue declined by 23.1% year-over-year, from $11.0M to $8.5M in fiscal year 2025.
Is US Global Invstr profitable?
No, US Global Invstr (GROW) reported a net income of -$334K in fiscal year 2025, with a net profit margin of -4.0%.
What is US Global Invstr's EBITDA?
US Global Invstr (GROW) had EBITDA of -$2.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is US Global Invstr's operating margin?
US Global Invstr (GROW) had an operating margin of -35.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is US Global Invstr's net profit margin?
US Global Invstr (GROW) had a net profit margin of -4.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does US Global Invstr pay dividends?
Yes, US Global Invstr (GROW) paid $0.01 per share in dividends during fiscal year 2025.
What is US Global Invstr's return on equity (ROE)?
US Global Invstr (GROW) has a return on equity of -0.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is US Global Invstr's free cash flow?
US Global Invstr (GROW) recorded an outflow of $829K in free cash flow during fiscal year 2025. This represents a -206.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is US Global Invstr's operating cash flow?
US Global Invstr (GROW) recorded an outflow of $822K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are US Global Invstr's total assets?
US Global Invstr (GROW) had $48.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are US Global Invstr's capital expenditures?
US Global Invstr (GROW) invested $7K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is US Global Invstr's current ratio?
US Global Invstr (GROW) had a current ratio of 20.87 as of fiscal year 2025, which is generally considered healthy.
What is US Global Invstr's debt-to-equity ratio?
US Global Invstr (GROW) had a debt-to-equity ratio of 0.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is US Global Invstr's return on assets (ROA)?
US Global Invstr (GROW) had a return on assets of -0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is US Global Invstr's Altman Z-Score?
US Global Invstr (GROW) has an Altman Z-Score of 10.62, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is US Global Invstr's Piotroski F-Score?
US Global Invstr (GROW) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are US Global Invstr's earnings high quality?
US Global Invstr (GROW) reported a net loss of $334K while operations used $822K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can US Global Invstr cover its interest payments?
US Global Invstr (GROW) reported an operating loss of $3.0M against $1K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is US Global Invstr?
US Global Invstr (GROW) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.